Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The changes in vitamin D levels were negatively correlated with the evolution of body weight (r = −0.344; p = 0.012), BMI (r = −0.311; p = 0.024), and preperitoneal AT (r = −0.300; p = 0.045), described in absolute terms.

Source: 3.4. Association Between Body Composition Changes and Biomarkers Evolution. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Observational study.

Observational study

Observes exposures and outcomes without assigning the exposure; the subtype is not established here.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This is a prospective observational study within the framework of the project “Lifestyle and Predictive Factors of Weight Gain in Women with Breast Cancer: The MAMAVIDA Project.” The study began in 2019, and recruitment is ongoing.

Source: Methods.

Participants were referred to the Nutrition Unit prior to the initiation of any treatment to undergo assessments of body composition and muscle strength.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Relationship Between Body Composition and Biomarkers in Adult Females with Breast Cancer: 1-Year Follow-Up Prospective Study

Observational study · Nutrients · 2025

Original publication title

Relationship Between Body Composition and Biomarkers in Adult Females with Breast Cancer: 1-Year Follow-Up Prospective Study

Angélica Larrad-Sáinz; María Gemma Hernández Núñez; Ana Barabash Bustelo; Inés Gil Prados; Johanna Valerio; José Luis Espadas Gil; María Eugenia Olivares Crespo; María Herrera de la Muela; Blanca Bernaldo Madrid; Irene Serrano García; Ignacio Cristóbal García; Miguel Ángel Rubio-Herrera; Alfonso Luis Calle-Pascual; Juana María Brenes Sánchez; Pilar Matía-Martín

© 2025 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Background/Objectives: After diagnosis, it is common for women with breast cancer to gain weight, which is associated with worse clinical outcomes. However, traditional measures such as body weight, BMI, and waist circumference do not detect key changes in body composition, such as fat redistribution or muscle loss. The objective of this exploratory study was to assess the evolution of body composition and muscle strength after one year of treatment, and their relationship with metabolic biomarkers. Methods: Prospective observational study in newly diagnosed breast cancer patients.

Body composition was assessed using bioelectrical impedance analysis (BIA) and ultrasound (US); muscle strength was measured by handgrip dynamometry. Biomarkers analyzed included glucose, insulin, Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), glycosylated hemoglobin (HbA1c), total cholesterol (and its fractions), triglycerides, C-reactive protein (CRP), 6-interleukin (IL-6), vitamin D, myostatin, and fibroblast growth factor 21 (FGF-21). Results: Sixty-one women (mean age 58 years) were included. After one year, fat mass and related parameters significantly increased, while skeletal muscle mass and muscle strength decreased.

Sarcopenic obesity prevalence rose from 1.16% to 4.9%. No significant changes were found in biomarkers, but positive correlations were observed between fat parameters and insulin, HOMA-IR, and triglycerides, and negative correlations with HDL-cholesterol. Conclusions: BIA and US can detect unfavorable changes in body composition that are not reflected in conventional measurements. At one year post-diagnosis, women showed increased fat accumulation, muscle loss, and reduced strength, even without significant metabolic biomarker changes. Further research is warranted to elucidate the long-term clinical implications of these findings and the external validity in larger cohorts.

Authors’ abstract

Background/Objectives: After diagnosis, it is common for women with breast cancer to gain weight, which is associated with worse clinical outcomes. However, traditional measures such as body weight, BMI, and waist circumference do not detect key changes in body composition, such as fat redistribution or muscle loss. The objective of this exploratory study was to assess the evolution of body composition and muscle strength after one year of treatment, and their relationship with metabolic biomarkers. Methods: Prospective observational study in newly diagnosed breast cancer patients.

Body composition was assessed using bioelectrical impedance analysis (BIA) and ultrasound (US); muscle strength was measured by handgrip dynamometry. Biomarkers analyzed included glucose, insulin, Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), glycosylated hemoglobin (HbA1c), total cholesterol (and its fractions), triglycerides, C-reactive protein (CRP), 6-interleukin (IL-6), vitamin D, myostatin, and fibroblast growth factor 21 (FGF-21). Results: Sixty-one women (mean age 58 years) were included. After one year, fat mass and related parameters significantly increased, while skeletal muscle mass and muscle strength decreased.

Sarcopenic obesity prevalence rose from 1.16% to 4.9%. No significant changes were found in biomarkers, but positive correlations were observed between fat parameters and insulin, HOMA-IR, and triglycerides, and negative correlations with HDL-cholesterol. Conclusions: BIA and US can detect unfavorable changes in body composition that are not reflected in conventional measurements. At one year post-diagnosis, women showed increased fat accumulation, muscle loss, and reduced strength, even without significant metabolic biomarker changes. Further research is warranted to elucidate the long-term clinical implications of these findings and the external validity in larger cohorts.

Publication and source details

Original title: Relationship Between Body Composition and Biomarkers in Adult Females with Breast Cancer: 1-Year Follow-Up Prospective Study

Angélica Larrad-Sáinz; María Gemma Hernández Núñez; Ana Barabash Bustelo; Inés Gil Prados; Johanna Valerio; José Luis Espadas Gil; María Eugenia Olivares Crespo; María Herrera de la Muela; Blanca Bernaldo Madrid; Irene Serrano García; Ignacio Cristóbal García; Miguel Ángel Rubio-Herrera; Alfonso Luis Calle-Pascual; Juana María Brenes Sánchez; Pilar Matía-Martín

Nutrients · 2025

* Correspondence: jbrenes@ucm.es (J.M.B.S.); mmatia@ucm.es (P.M.-M.)
†

These authors contributed equally to this work.

© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Sociedad de Endocrinología, Nutrición y Diabetes de la Comunidad de Madrid (SENDIMAD)Fundación de la Sociedad Española de Endocrinología y Nutrición (SEEN)Fundación de Investigación en Nutrición y Metabolismo (FINUMET)European Union: NextGenerationEU, through the Instituto de Salud Carlos III (ISCIII), Ministry of Science, Innovation and UniversitiesAC21_2/00036This research was funded by Sociedad de Endocrinología, Nutrición y Diabetes de la Comunidad de Madrid (SENDIMAD) (2020), Fundación de la Sociedad Española de Endocrinología y Nutrición (SEEN) (2020), and Fundación de Investigación en Nutrición y Metabolismo (FINUMET) (2025). This work was also funded within the framework of project AC21_2/00036 by the European Union: NextGenerationEU, through the Instituto de Salud Carlos III (ISCIII), Ministry of Science, Innovation and Universities, in the context of the Government of Spain’s Recovery, Transformation, and Resilience Plan.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:21:38.012236+00:00

DOI: 10.3390/nu17152487 · PMC12348593